Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Koninklijke Philips NVRYLPF -8.59%71 Capex-to-Operating-Cash-Flow is 0.42 as of Jun. 2026, which is 11% below its 10-year median of 0.47. GuruFocus rates RYLPF with a GF Scoreâ„¢ of 71/100 and a GF Valueâ„¢ of $26.40 (Fairly Valued). The stock has 2 warning signs investors should review. Among 440 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 63.18% on this metric.
Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.
Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.
Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.
Koninklijke Philips NV Capex-to-Operating-Cash-Flow Related Terms
Koninklijke Philips NV Capex-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Koninklijke Philips NV's Capex-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RYLPF vs ABT, SYK, MDT: Capex-to-Operating-Cash-Flow Comparison
For the Medical Devices subindustry, Koninklijke Philips NV's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV Capex-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Capex-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's Capex-to-Operating-Cash-Flow falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Cash-Flow of 0.42 mean?
Koninklijke Philips NV (RYLPF) has a Capex-to-Operating-Cash-Flow of 0.42 as of Jun. 2026. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Koninklijke Philips NV and its competitors. This is 11% below median its historical median of 0.47. Over the past decade, Koninklijke Philips NV's Capex-to-Operating-Cash-Flow has ranged from 0.29 to 0.65. According to the industry distribution chart, Koninklijke Philips NV ranks #162 out of 440 companies in the Medical Devices & Instruments industry, placing it in the top 36.8%.
Is Koninklijke Philips NV's Capex-to-Operating-Cash-Flow too high?
Koninklijke Philips NV's current Capex-to-Operating-Cash-Flow of 0.42 is 11% below median its 10-year median of 0.47. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 0.65. The Medical Devices & Instruments industry median Capex-to-Operating-Cash-Flow is 0.41. Koninklijke Philips NV's value of 0.42 is 2.4% above this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #162 out of 440 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Scoreâ„¢ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Capex-to-Operating-Cash-Flow compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #162 out of 440 companies for Capex-to-Operating-Cash-Flow. This puts Koninklijke Philips NV in the upper half of its industry. The industry median Capex-to-Operating-Cash-Flow is 0.41. Koninklijke Philips NV's value of 0.42 is 2.4% above this benchmark. Historically, Koninklijke Philips NV's own Capex-to-Operating-Cash-Flow has ranged from 0.29 to 0.65 over the past decade. While the company's 10-year median is 0.47 vs. the industry median of 0.41, Koninklijke Philips NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Cash-Flow for a Medical Devices & Instruments company?
The median Capex-to-Operating-Cash-Flow among Medical Devices & Instruments companies is 0.41, based on 440 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Capex-to-Operating-Cash-Flow of 0.42 is 2.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Cash-Flow mean?
A high Capex-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Capex to Operating Cash Flow ratio assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Capex-to-Operating-Cash-Flow is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Capex-to-Operating-Cash-Flow is 0.42, which is 11% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $26.40, compared to a current price of $25.21 — trading 4.5% below its estimated fair value. The current Capex-to-Operating-Cash-Flow is 0.42, which is 11% below median its 10-year median of 0.47 and 2.4% above the Medical Devices & Instruments industry median of 0.41. Koninklijke Philips NV's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Cash-Flow calculated?
Capex-to-Operating-Cash-Flow is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Capex-to-Operating-Cash-Flow is 0.42 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be undervalued.
The current stock price of $25.21 is trading 4.5% below its estimated GF Value™ of $26.40.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
Capex-to-Operating-Cash-Flow: 0.42 (11% below median its 10-year median of 0.47)
GF Value™: $26.40 vs. price of $25.21 (4.5% below fair value)
Industry Position: 2.4% above the Medical Devices & Instruments median (#162 of 440)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
71GF Score
Get the complete analysis for RYLPF
Capex-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
